Abnormalities of erythrocyte glycoconjugates are identical in two families with congenital dyserythropoietic anemia type II with different chromosomal localizations of the disease gene
Glycophorin A in two patients with congenital dyserythropoietic anemia type I and type II is partly unglycosylated
Zdebska E, Adamczyk-Poplawska M, Koscielak J. Glycophorin A in two patients with congenital dyserythropoietic anemia type I and type II is partly unglycosylated. Acta Biochim Polon 2000;47:773-9.
Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search
Gasparini P, del Giodice EM, Delaunay J, Delaunay J, Totaro A, Granatiero M, et al. Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search. Am J Hum Genet 1997; 61:1112-6.
Genetic heterogeneity of congenital dyserythropoietic anemia type II
Iolascon A, De Mattia D, Perrotta S, Carella M, Gasparini P, Lambertenghi Deliliers G. Genetic heterogeneity of congenital dyserythropoietic anemia type II. Blood 1998; 92:2593-4.
Heterozygosity of CDAN2 (HEMPAS) gene may be detected by the analysis of erythrocyte membrane glycoconjugates from healthy carriers
Zdebska E, Mendek-Czajkowska E, Ploski R, Woeniewicz B, Koscielak J. Heterozygosity of CDAN2 (HEMPAS) gene may be detected by the analysis of erythrocyte membrane glycoconjugates from healthy carriers. Haematologica 2002;87:126-30.
Glycoconjugate abnormalities in patients with congenital dyserythropoietic anaemia type I, II and III
Zdebska E, Golaszewska E, Fabijanska-Mitek J, Schachter H, Shalev H, Tamary H, et al. Glycoconjugate abnormalities in patients with congenital dyserythropoietic anaemia type I, II and III. Br J Haematol 2001;114:907-13.
Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency
Paw BH, Davidson AJ, Zhou Y, Li R, Pratt SJ, Lee C, et al. Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency. Nat Genet 2003;34:59-64.
Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis
King MJ, Smythe JS, Mushens R. Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis. Br J Haematol 2004;124:106-13.